Alzheimer's disease costs: What we know and what we should take into account

Journal of Alzheimer's Disease

Volumn 42, Issue 4, 2014, Pages 1311-1324

  Colucci, Luisa ^a,b   Bosco, Massimiliano ^b   Fasanaro, Angiola Maria ^b   Gaeta, Giuseppe Lucio ^c   Ricci, Giovanna ^a   Amenta, Francesco ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b Azienda Ospedaliera Rilievo Naz A   (Italy)

^c Università di Napoli l'Orientale   (Italy)

Author keywords

Costs of Alzheimer's disease; direct costs; evaluation costs; indirect costs; intangible costs; total costs

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; COMMUNITY CARE; COST OF ILLNESS; DAILY LIFE ACTIVITY; DATA BASE; DELUSION; DISEASE SEVERITY; DRUG COST; EMERGENCY CARE; HALLUCINATION; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; INSTITUTIONAL CARE; MEDICAL CARE; MEDICAL EXAMINATION; MENTAL HEALTH SERVICE; MINI MENTAL STATE EXAMINATION; ONSET AGE; OUTPATIENT CARE; PATIENT AUTONOMY; QUALITY OF LIFE; RESIDENTIAL CARE; RESPITE CARE; SLEEP DISORDER; SOCIAL STATUS; SYSTEMATIC REVIEW; ECONOMICS; HEALTH CARE COST; STATISTICS AND NUMERICAL DATA;

ALZHEIMER DISEASE; COST OF ILLNESS; HEALTH CARE COSTS; HUMANS;

EID: 84908004120     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-131556     Document Type: Article

References (40)

1. Alzheimer's, Association (2010) Alzheimer's disease facts and figures. Alzheimers Dement 6, 158-194.
2. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP (2013) The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement 9, 63-75.
3. Fillit HM (2000) The pharmacoeconomics of Alzheimer's disease. Am J Manag Care 6, S1139-S1144.
4. Zhu CW, Sano M (2006) Economic considerations in the management of Alzheimer's disease. Clin Interv Aging 1, 143-154.
5. Costa N, Ferlicoq L, Derumeaux-Burel H, Rapp T, Garnault V, Gillette-Guyonnet S, Andrieu S, Vellas B, Lamure M, Grand A, Molinier L (2013) Comparison of informal care time and costs in different age-related dementias: A review. Biomed Res Int 2013, 852368.
6. Mauskopf J, Racketa J, Sherrill E (2010) Alzheimer's disease: The strength of association of costs with different measures of disease severity. J Nutr Health Aging 8, 655-663.
7. Jönsson L, Wimo A (2009) The cost of dementia in Europe: A review of the evidence, and methodological considerations. Pharmacoeconomics 5, 391-403.
8. Wells G, Shea B, O'Connell D, Robertson J, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. http://www.ohri.ca/programs/clinical epidemiology/oxford.asp. Last updated July 6, 2000, Accessed on January 8, 2013.
9. Gustavsson A, Brinck P, Bergvall N, Kolasa K, Wimo A, Winblad B, Jönsson L (2011) Predictors of costs of care in Alzheimer's disease:A multinational sampleof1222 patients. Alzheimers Dement 3, 318-327.
10. Miller EA, Rosenheck RA, Schneider LS (2010) Assessing the relationship between health utilities, quality of life, and health care costs in Alzheimer's disease: The CATIE-AD study. Curr Alzheimer Res 7, 348-357.
11. Gillespie P, O'Shea E, Cullinan J, Lacey L, Gallagher D, Ni Mhaolain A (2013) The effects of dependence and function on costs of care for Alzheimer's disease and mild cognitive impairment in Ireland. Int J Geriatr Psychiatry 3, 256-264.
12. Gallagher D, Mhaolain AN, Coen R, Walsh C, Kilroy D, Belinski K, Bruce I, Coakley D, Walsh JB, Cunningham C, Lawlor BA (2010) Detecting prodromal Alzheimer's disease in mild cognitive impairment: Utility of the CAMCOG and other neuropsychological predictors. Int J Geriatr Psychiatry 12, 1280-1287.
13. Wimo AW, Winblad B (2003) Resource utilization in dementia: RUD Lite. Brain Aging 1, 48-59.
14. Rapp T, Andrieu S, Molinier L, Grand A, Cantet C, Mullins CD, Vellas B (2012) Exploring the relationship between Alzheimer's disease severity and longitudinal costs. Value Health 3, 412-419.
15. Coduras A, Rabasa I, Frank A, Bermejo-Pareja F, López-Pousa S, López-Arrieta JM, Del Llano J, León T, Rejas J (2010) Prospective one-year cost-of-illness study in a cohort of patients with dementia of Alzheimer's disease type in Spain: The ECO study. J Alzheimers Dis 2, 601-615.
16. Herrmann N, Tam DY, Balshaw R, Sambrook R, Lesnikova N (2010) The relation between disease severity and cost of caring for patients with Alzheimer disease in Canada. Can J Psychiatry 55, 768-775.
17. Reese JP, Hessmann P, Seeberg G, Henkel D, Hirzmann P, Rieke J, Baum E, Dannhoff F, Müller MJ, Jessen F, Geld-setzer MB, Dodel R (2011) Cost and care of patients with Alzheimer's disease: Clinical predictors in German health care settings. J Alzheimers Dis 27, 723-736.
18. Hurd MD, Martorell P, Delavande A, Mullen KJ, Langa KM (2013) Monetary costs of dementia in the United States. N Engl J Med 14, 1326-1334.
19. Chhatrea S, Weiner MG, Jayadevappa R, Johnson JC (2009) Incremental burden of congestive heart failure among elderly with Alzheimer's. Aging Ment Health 13, 628-634.
20. Luengo-Fernandez R, Leal J, Gray AM (2011) Costofdemen-tia in the pre-enlargement countries of the European Union. J Alzheimers Dis 27, 187-196.
21. Wimo A, Jönsson L, Gustavsson A, McDaid D, Ersek K, Georges J, Gulácsi L, Karpati K, Kenigsberg P, Valtonen H (2011) The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project. Int J Geriatr Psychiatry 26, 825-832.
22. Wimo A, Jönsson L, Bond J, Prince M, Winblad B (2013) The worldwide economic impact of dementia 2010. Alzheimers Dement 1, 1-11.e3.
23. Oremus M, Aguilar SC (2001) A systematic review to assess the policy-making relevance of dementia cost-of-illness studies in the US and Canada. Pharmacoeconomics 2, 141-156.
24. Costa N, Ferlicoq L, Derumeaux-Burel H, Rapp T, Garnault V, Gillette-Guyonnet S, Andrieu S, Vellas B, Lamure M, Grand A, Molinier L (2013) Comparison of informal care time and costs in different age-related dementias: A review. Biomed Res Int 2013, 852368.
25. McLaughlin T, Buxton M, Mittendorf T, Redekop W, Mucha L, Darba J, Jonsson L, Lacey L, Leibman C (2010) Assessment of potential measures in models of progression in Alzheimer disease. Neurology 14, 1256-1262.
26. Mohide EA, Torrance GW, Streiner DL, Pringle DM, Gilbert R (1988) Measuring the wellbeing of family caregivers using the time trade-off technique. J Clin Epidemiol 5, 475-482.
27. EuroQol Group (1990) EuroQol: A new facility for the measurement of health-related quality of life. Health Policy 3, 199-208.
28. Brouwer WBF, van Exel NJA, van Gorp B, Redekop WK (2006) The CarerQol instrument: A new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations. Qual Life Res 6, 1005-1021.
29. McMillan SC, Mahon M (1994) The impact of hospice services on the quality of life of primary caregivers. Oncology Nursing Forum 7, 1189-1195.
30. Novak M, Guest C (1989) Application of multidimensional caregiver burden inventory. Gerontologist 29, 798-803.
31. Robinson BC (1983) Validation of a Caregiver Strain Index. J Gerontol 3, 344-348.
32. Given CW, Given B, Stommel M, Collins C, King S, Franklin S (1992) The caregiver reaction assessment (CRA) for caregivers to persons with chronic physical and mental impairments. Res Nurs Health 4, 271-283.
33. Vernooij-Dassen MJFJ, Persoon JMG, Felling AJA (1996) Predictors of sense of competence in caregivers of demented persons. Soc Sci Med 1, 41-49.
34. van Exel NJ, Scholte op Reimer WJ, Brouwer WB, van den Berg B, Koopmanschap MA, van den Bos GA (2004) Instruments for assessing the burden of informal caregiving for stroke patients in clinical practice: A comparison of CSI, CRA, SCQ and self-rated burden. Clin Rehabil 2, 203-214.
35. Wang HX, Karp A, Winblad B, Fratiglioni L (2002) Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: A longitudinal study from the Kungsholmen Project. Am J Epidemiol 155, 1081-1087.
36. Ready RE (2007) Commentary on "Health economics and the value of therapy in Alzheimer's disease." Patient-reported outcomesinclinicaltrials forAlzheimer's disease. Alzheimers Dement 3, 172-176.
37. Gaeta GL, Ercolano S (2010) Assistenza informale e malat-tia di Alzheimer: I risultati di un'indagine sul campo. In La Memoria Dimenticata: Malattia di Alzheimer e Costi della Assistenza, Fasanaro AM, ed. CMP Edizioni, Roma pp. 32-7.
38. Ciriacy-Wantrup SV (1947) Capital returns from soil conservation practices. J Farm Econ 29, 1188-1190.
39. Van Den Berga B, Al M, Brouwer W, Van Exel J, Koopman-schap B (2005) Economic valuation of informal care: The conjoint measurement method applied to informal caregiving. Soc Sci Med 61, 1342-1355.
40. Mittelman MS, Roth DL, Clay OJ, Haley WE (2007) Preserving health of Alzheimer caregivers: Impact of a spouse caregiver intervention. Am J Geriatr Psychiatry 15, 780-789.